APA (7th ed.) Citation

MD, H., KJ, B., HE, J., GJ, P., MA, F., BC, D., . . . SP, S. (2023). Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval. The journal of prevention of Alzheimer's disease, 10(4), 765. https://doi.org/10.14283/jpad.2023.96

Chicago Style (17th ed.) Citation

MD, Howe, Britton KJ, Joyce HE, Pappas GJ, Faust MA, Dawson BC, Riddle MC, and Salloway SP. "Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval." The Journal of Prevention of Alzheimer's Disease 10, no. 4 (2023): 765. https://doi.org/10.14283/jpad.2023.96.

MLA (9th ed.) Citation

MD, Howe, et al. "Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval." The Journal of Prevention of Alzheimer's Disease, vol. 10, no. 4, 2023, p. 765, https://doi.org/10.14283/jpad.2023.96.